þ T cells demonstrate reduced expression of tumor necrosis factor-a (TNF-a) and interferon-c (IFN-c), whereas maintaining equivalent interleukin-2 (IL-2) levels, as compared with adult peripheral blood (PB) CD4 þ T cells. Nuclear factor of activated T cells (NFAT1) protein, a transcription factor known to regulate the expression of IL-2, TNF-a and IFN-c, is reduced in resting and activated UCB CD4 þ T cells. In contrast, expression of Broad-complex-Tramtrack-Bric-a-Brac and Cap'n'collar homology 1 bZip transcription factor 2 (BACH2) was shown by gene array analyses to be increased in UCB CD4 þ T cells and was validated by qRT-PCR. Using chromatin immunoprecipitation, BACH2 was shown binding to the human IL-2 proximal promoter. Knockdown experiments of BACH2 by transient transfection of UCB CD4 þ T cells with BACH2 siRNA resulted in significant reductions in stimulated IL-2 production. Decreased IL-2 gene transcription in UCB CD4
Introduction

Umbilical cord blood (UCB) graft T cells are predominantly (490%) CD4
þ and express a naive (CD45RA þ ) phenotype with little or no CD45RO þ expression; this differs significantly when compared with adult CD4 þ T cells infused in conventional allogeneic bone marrow or mobilized peripheral blood (PB) stem cell grafts. 1 On CD3/CD28 stimulation, UCB graft T cells express activation markers equivalent to adult CD4 þ T cells, as measured by downregulation of CD45RA þ and upregulation of CD25, CD69, T-cell receptor (TCR/CD3) and p56
Ick . 2 During primary T-cell receptor stimulation, UCB T-cell proliferation is equal to adult, as measured by thymidine incorporation. 3 Finally, UCB T-cell proliferation after secondary stimulation has been shown to be significantly reduced, and alloantigen-specific cytotoxicity is also decreased, thus reducing their response to foreign antigens. 4, 5 Resting UCB CD4 þ T cells have lower constitutive nuclear factor of activated T cells 1 (NFAT1) protein expression and delayed upregulation of this transcription factor during primary stimulation compared with adult PB CD4 þ T cells. 6, 7 Importantly, activated UCB CD4 þ T-cell production of NFAT1 regulated cytokines: interferon-g (IFN-g) and tumor necrosis factor-a (TNF-a), are significantly reduced compared with adult PB CD4 þ T cells. 1, 8 Further, microarray analyses of activated UCB CD4
þ T cells demonstrate maintained IL-2 expression compared with activated adult PB CD4 þ T cells. 7 Enzymelinked immunosorbent assay studies have confirmed equivalent IL-2 production in resting and activated UCB CD4 þ compared with adult PB CD4 þ T cells. 6, 9 At the same time points of reduced NFAT1 protein during primary T-cell stimulation, a threefold higher expression of the 110 kDa protein, Broadcomplex-Tramtrack-Bric-a-Brac and Cap'n'collar homology 1 bZip transcription factor 2 (BACH2) has been observed in gene expression analyses, whereas JunB and FRA1 are reduced in UCB CD4 þ T cells relative to adult. 6 Interleukin-2 (IL-2) has emerged as a critical regulatory cytokine in the development of acquired immunity. IL-2 is immune enhancing (that is, proproliferation, survival and differentiation of naive T cells into effector and memory subtypes). 10 Exogenous IL-2 stimulates the proliferation of anergenic T cells. 11 IL-2 also promotes activation-induced cell death and is a factor for maintaining the homeostasis of regulatory T cells (T reg ) in vivo, 12 but can also provide T-cell protection from apoptosis by upregulating the expression of the antiapoptotic protein bcl-2. 13 Exogenous addition of IL-2 to UCB CD4 þ T cells results in proliferation and in vitro preferential development of T reg .
14 Current models of IL-2 gene regulation during CD4 þ T-cell activation suggest that NFAT1, activating protein 1 dimer (AP1-Jun:Fos) and NF-kB, all bind to the human IL-2 proximal promoter to promote IL-2 production. 15, 16 Further studies have determined that NFAT1 is required for AP1 to bind to the combined NFAT1:AP1 sites on the IL-2 promoter. [17] [18] [19] Nonetheless, NFAT1 and AP1 are significantly lower in UCB CD4 þ T cells. 6 This report summarizes studies demonstrating a functional role for BACH2 in UCB CD4 þ T cells. BACH2 expression is upregulated in UCB CD4 þ T cells relative to adult PB CD4 þ T cells as seen by gene array and confirmed by quantitative realtime PCR (qRT-PCR) and western blot. In addition, BACH2
promotes IL-2 expression in UCB CD4 þ T cells via binding to the IL-2 proximal promoter as determined by chromatinimmunoprecipitation (ChIP) assay and luciferase activity. Taken together, we present evidence that before and during stimulation; UCB CD4 þ T cells maintain equivalent IL-2 expression due to BACH2 regulation of IL-2 gene expression in the setting of reduced NFAT1 protein.
Materials and methods
CD4
þ T-cell selection and stimulation
The T-cell lines Loucy and MOLT-4 cells were obtained from American Type Culture Collection, Virginia. Acquisition of both adult and UCB mononuclear cells conformed to Case Western Reserve University's IRB protocol no. 3937. Human UCB and adult PB mononuclear cells were collected and purified as described. 20 Naive CD4 þ T cells were purified using Miltenyi naive T-cell kit and total CD4 þ T cells were purified by sequential CD14
À and CD4 þ selection using the Miltenyi autoMACS system (Auburn, CA, USA) per manufacturer's instructions. Purity was assessed by multiparameter flow cytometry utilizing fluorochrome-conjugated antibodies (Abs) against CD3, CD4, CD14, CD56 and corresponding isotype controls (Pharmingen, San Jose, CA, USA). The purity of selected UCB and adult PB CD4 þ T cells ranged from 80 to 97% (data not shown). Purified UCB and adult PB CD4 þ T cells were stimulated by incubation with adherent anti-CD3 Abs (1 mg/ml) and anti-CD28 Abs (5 mg/ml) in RPMI-1640 media with 0.3 g/l L-glutamine supplemented with 1 mM sodium pyruvate, 0.1 mM minimal essential amino acids plus 10% fetal bovine serum, here referred to as complete RPMI.
Transfection of primary UCB or adult CD4
þ T cells UCB CD4 þ T cells were prepared for electroporation using the Amaxa Nucleofector system (Gaithersburg, MD, USA). Between 1 Â 10 6 and 6 Â 10 6 CD4 þ T cells were resuspended in 100 ml of unstimulated primary T-cell Nucleofector solution along with 2 mg of pGL3hIL-2 firefly luciferase plasmid, 100 ng of pGL3TK Renilla (Promega, Madison, WI, USA), 2 mg nonspecific random siRNA sequence (control siRNA) that does not induce any specific inhibition (Dharmacon, Lafayette, CO, USA), or 2.6 mg 'SMARTPool' siRNAs (Dharmacon) targeting BACH2 mRNA. Electroporated cells were allowed to recover in 1.5 ml of complete RPMI media for 24 h. The cells were harvested at this time or stimulated 6 h as described in CD4 þ T-cell selection and stimulation.
Quantitative RT-PCR
RNA was isolated from primary CD4 þ T cells using Trizol reagent (Invitrogen, Carlsbad, CA, USA) and quantified by standard spectrophotometric assays. NFAT1, BACH2, IL-2 and b2-microglobulin (B2M) mRNAs were measured by quantitative real-time (qRT-PCR). B2M was used as an internal control. 21, 22 The qRT-PCR runs were performed in triplicate to quantify expression levels for each of these genes using the Lightcycler SybrGreen real-time RT-PCR system (Roche, Basel, Switzerland). The primers used were: BACH2 forwardFATGCACA AGCTAACCTCAGA, BACH2 reverseFTCACTAGGTATAATCT TTCCTG; NFAT1 forwardFGATGGTGGCCGAGTCCC, NFAT1 reverseFCGGCTCTTTGGCTCGTGGCA; IL-2 forwardFTGGA GCATTTACTGCTGGATT, IL-2 reverseFAGCCCCTAGGGCTT ACAAAA; B2M forwardFGTGCTCGCGCTACTCTCTCT, B2M reverseFTCTCTGCTCCCCACCTCTAA. 23 The REST program uses a pairwise fixed reallocation randomization test to calculate the absolute gene regulation as well as the significance of observed changes. The data is presented as the relative gene expression±s.e.m.
Statistical analysis of qRT-PCR
Western blot
Cells from resting and stimulated UCB and adult CD4 þ T cells were lysed using radioimmuno precipitation assay buffer, 24 and protein was quantitated using the Bicinchoninic acid (BCA) assay (Bio-Rad, Hercules, CA, USA), and 40 mg of protein were separated by 10% sodium dodecyl sulfate-PAGE. Membranes were immunoblotted with goat anti-BACH2 (E16) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-IL-2 (Abcam, Cambridge, MA, USA) and anti-b-actin Abs (Sigma, St Louis, MO, USA). Western blots were quantified with NIH J Image program and the data presented as relative protein expression ± s.e.m.
Identification of putative transcriptional BACH2-binding sites
The sequence 1 kb upstream of the IL-2 translation start site (http://www.ncbi.nlm.nih.gov/sites/entrez) was processed for putative transcription factor-binding sites specifically, NFAT1 (A/T)GGAAA-and AP1-binding sites, (G/A)(G/C)TGA(G/C) TCA(T/G)(A/T) using TESS (transcription element search system) at http://www.cbil.upenn.edu/cgi-bin/tess/tess. 25 This region was reexamined manually for the same sites, with attention to regions adjacent to the NFAT1-binding sites for partial AP1 sites possibly missed by the algorithm. Regions of interest were aligned manually and examined for similarity to the known BACH2 consensus sequence TGA(G/C)TCA(T/C). 26 Sequences with 475% (that is, p2 mismatches) similarity to the BACH2 consensus site are indicated in Figure 3 .
Chromatin-immunoprecipitation of BACH2-and DNA-binding sites from UCB CD4 þ T cells
were formaldehyde treated and processed as described. 27 ChIP lysates were immunoprecipitated with 20 mg anti-BACH2 (Santa Cruz Biotechnology), 25 mg anti-NFAT1 (BD Transduction, San Jose, CA, USA), 20 mg anti-JunB (Santa Cruz Biotechnology) or 20 mg anti-MafK (Santa Cruz Biotechnology) Abs, then immunoprecipitated with protein A/G agarose beads (Bio-Rad). After proteolytic digestion, eluted DNA was examined for the IL-2 proximal promoter (B500 bp region) by standard PCR. 27 Primers used were: IL-2 forward-TTGCTCCAGTTGTAGCTGTG TTT and IL-2 reverse-CCACCCCCTTAAAGAAAGGA.
pGL3-luciferase plasmid constructs
The pGL3 luciferase and pGL3 Renilla expression plasmids were purchased from Promega. In addition, Dr A Avots (Pathologisches Institut Wü rzburg, Germany) graciously provided a pGL3hIL-2 firefly luciferase expression vector 28 containing the 503 base pair region from À499 to þ 5 of the human IL-2 gene cloned into the pGL3 basic vector.
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BACH2 regulates IL-2 in umbilical cord blood CD4 þ T cells ML Lesniewski et al Dual-luciferase reporter assay system was used to measure both firefly luciferase and Renilla luciferase activity (Promega). The standard protocol for a dual injector luminometer was followed. Briefly, transfected cells were harvested by centrifugation and lysed using the passive lysis buffer and 20 ml of cell lysate was transferred into the luminometer plate and mixed with 100 ml LARII. Ten-second measurements were initiated for each reporter assay and recorded. After firefly luciferase readings, the luminescence was quenched and lysates reread for the Renilla luciferase activity. The ratio of firefly to Renilla luciferase activity was calculated in order to normalize for the assay variation. Relative light units were then compared to determine the amount of respective promoter activity.
Results
Expression of bZip transcription factors in UCB CD4
þ
T cells
On the basis of previous gene array data, 6 we examined transcription factors responsible for IL-2 expression and related family genes comparing expression in UCB and adult CD4 þ T cells at baseline resting state and at 6 h primary stimulation. Increased BACH2 mRNA expression in UCB CD4 þ T cells is confirmed, with a fourfold higher mRNA expression in UCB CD4 þ T cells, compared with adult ( Figure 1a ). We next examined whether at the protein level there was also higher expression of BACH2 in UCB CD4 þ T cells. BACH2 protein expression is noted to be higher in total UCB CD4 þ T cells, when compared with adult PB CD4 þ T cells (Figure 1b ). To determine whether higher expression of BACH2 in UCB is due to a predominance of naive CD4 þ T cells, we compared expression of BACH2 protein in purified UCB naive T cells to naive adult PB CD4 þ T cells. UCB naive CD4 þ T cells BACH2 expression was noted to be significantly higher (Po0.05) than that measured in naive adult PB CD4 þ T cells (Figure 1c ).
Knockdown of BACH2 with siRNA in UCB CD4
T cells results in decreased IL-2 expression
Next, we examined whether the transcription factor BACH2 may regulate the expression of IL-2 in UCB CD4 þ T cells. For this, we transfected freshly isolated UCB CD4 þ T cells with BACH2 siRNA and assayed BACH2 and IL-2 mRNA expression 24 h after electroporation. Figure 2a shows that the knockdown of BACH2 mRNA was very efficient (420-fold), albeit transient, as BACH2 mRNA levels increased after 24 h. Loss of BACH2 expression at 24 h after transfection correlated with a 142-fold lower expression of IL-2 and remained 27-fold lower after 6 h of stimulation (30 h after transfection) (Figure 2a) . Treating UCB CD4 þ T cells with BACH2 siRNA resulted in a BACH2 protein decrease of 51.7±7.2% (P ¼ 0.001) compared with control siRNA-treated UCB CD4 þ T cells (Figure 2d ). At the same time, the amount of IL-2 protein decreased by an average 78.9 ± 12.1% (P ¼ 0.0004) of control siRNA-treated UCB CD4 þ T cells (Figure 2d ).
BACH2 putative consensus DNA-binding domains located within the IL-2 proximal promoter
We next determined if BACH2-binding sites could be found within the IL-2 proximal promoter. Previous reports have determined that the AP1 site associated with the NFAT1-binding region would be unoccupied in the absence of NFAT1 protein. 17, 30 Sequence comparison of the IL-2 promoter revealed that the known AP1-binding sites had 475% similarity to the BACH2 consensus DNA-binding sequence, including the AP1 sites associated with the NFAT1-binding sites (Figure 3 ).
BACH2 binds to the IL-2 proximal promoter in resting UCB CD4 þ T cells
To determine if BACH2 can bind to the human IL-2 proximal promoter, ChIP assays were performed. The target IL-2 promoter was detected by standard PCR using primers encompassing the region containing these putative BACH2 sites. Figure 4a shows control reactions and includes ChIP experiments using BACH2 Ab (lane 4). Figure 4b shows 
BACH2 activates transcription at the proximal IL-2 promoter in UCB CD4 þ T cells
The identification of the IL-2 promoter sequence from ChIP data suggests that BACH2 is present at the IL-2 promoter region but does not demonstrate that it can function as a transcriptional activator for IL-2 gene expression. In order to determine if BACH2 activates IL-2 gene expression, a luciferase reporter assay was employed. UCB CD4 þ T cells were transfected with a luciferase reporter plasmid with either BACH2 specific or control siRNA. IL-2 promoter-driven expression of luciferase gene in UCB CD4
þ T cells containing control siRNA exhibited enhanced luciferase activity compared with control. When cells were cotransfected with BACH2 siRNA, the IL-2 promoterdriven luciferase expression decreased 2.6-fold (Po0.05) ( Figure 5 ), demonstrating BACH2's functional role in activating the IL-2 gene. These analyses confirm that BACH2 binds and transcriptionally activates the IL-2 proximal promoter.
Discussion
UCB allogeneic stem cell grafts differ from adult donor marrow and mobilized PB in that the T-cell population is predominantly (490%) naive with noted skewing toward a Th2 response on primary stimulation. 1, 31 In addition, UCB CD4 þ T cells differ from adult CD4 þ /CD45RA þ by the suppression of NFAT1 protein expression. 20 In addition, UCB CD4 þ T cells elicit reduced Th1 responses, including TNF-a and IFN-g expression. 6 This would be expected due to the absence of NFAT1 protein in naive (CD45RA þ ) UCB CD4 þ T cells. 20 Nonetheless, these same studies have noted that IL-2, a critical regulatory Th1 cytokine, 6, 32 which is also required for T reg homeostasis, 33, 34 demonstrates equivalent expression in UCB versus adult CD4 þ T cells. This dichotomy supports the concept of alternative IL-2 regulation in the absence of NFAT1 protein in UCB graft CD4 þ T cells. Previous analyses have shown that BACH2 is undetectable in primary adult human CD3 þ T cells, 35 but is expressed in the BACH2 regulates IL-2 in umbilical cord blood CD4 þ T cells ML Lesniewski et al T-cell leukemia cell lines: Jurkat and CEM. 36, 37 BACH2 was expressed at higher levels in UCB CD4
þ population compared with adult CD4 þ T cells. Herein, we report BACH2 expression in primary UCB CD4 þ T cells, and BACH2's ability to promote IL-2 transcription in the absence of NFAT1 in UCB CD4 þ T cells. BACH2 has previously been described in neuronal brain cells, spleen, developing fetal limb buds, and differentiating B cells. [38] [39] [40] BACH2 can repress transcription of the immunoglobulin heavy chain gene during B-cell differentiation. 35 In addition, BACH2 reduces B-cell proliferation, is involved in Ab class switching, is functional in reactive oxidative stress-induced apoptosis and is classified as a tumor suppressor gene. 38, 41 There has not been any role assigned to BACH2 in normal human T cells before this study. 
BACH2's function in UCB CD4
þ T-cell regulation was examined, by transient knockdown using BACH2 siRNA, followed by measuring the mRNA expression of Th1 cytokines. We chose the Th1 cytokines because their expression was previously determined to differ in UCB CD4
þ T cells compared with adult CD4 þ T cells. 3 qRT-PCR and western blot revealed significant loss of IL-2 expression in the BACH2 siRNA-treated UCB CD4 þ T cells. This was an unexpected finding. Although previous studies have shown that NFAT1 and AP1 are necessary for NFAT1:AP1 activation of the IL-2 gene, 15, 42 and that NFAT1 protein is significantly reduced in UCB CD4 þ T cells, 20 lower IL-2 expression in UCB CD4
þ T cells has not been previously reported. 7, 20 However, the inhibition of IL-2 prompted a re-examination of IL-2 regulation in UCB CD4 þ T cells. The IL-2 promoter has four identified AP1 sites. In addition, BACH2 and AP1 are members of the bZip protein family and their consensus DNAbinding site has significant sequence homology including the two AP1 sites dependent on NFAT1. 19, 42 This suggests that BACH2 may be capable of binding to the IL-2 promoter in the absence of NFAT1 protein. The hypothesis that BACH2 binds directly to the IL-2 proximal promoter was confirmed by ChIP analysis. In addition, BACH2 was shown not to bind to the IL-2 promoter in adult CD4 þ T cells. Finally, BACH2 functionality as a positive transcription factor for IL-2 was confirmed by luciferase assays. Thus, BACH2 activates IL-2 transcription by directly binding to the IL-2 proximal promoter in the setting of reduced NFAT1 protein in UCB CD4 þ T cells. We propose the following model of IL-2 activation in UCB graft CD4 þ T cells: on CD3 and CD28 engagement, the downstream signals likely propagate normally through the JNK, MAPK and NF-kB pathways. However, the NFAT1 pathway terminates at NFAT1, but calcium release and calmodulin would still function, activating additional pathways such as protein kinase C y. The absence of NFAT1 protein implies those binding sites dependent on active NFAT1 would be available for alternative transcription factors. In the UCB CD4 þ T-cell, this would include the NFAT1: AP1 consensus site because the complete ternary complex is required for proper binding to these sites. 17 Alternative bZip protein complexes could competitively bind at vacant AP1 sites within various Th1 cytokine promoters.
We suspect it is in this configuration that an activated BACH2 binds to the IL-2 promoter and compensates for the lack of NFAT1 thereby stimulating IL-2 mRNA transcription. This results in equivalent levels of IL-2 expression by UCB CD4 þ T cells without the concurrent activation of other NFAT1-regulated pathways, thereby contributing in part to the unique cytokine profile of UCB graft CD4 þ T cells. 6 This unique expression of BACH2 and NFAT1 in UCB CD4 þ T cells is not attributable to their naïve phenotype alone as adult CD4 þ CD45RA þ T cells do not express increased BACH2 nor reduced NFAT1 protein expression. 20 Our current model of BACH2 function does not exclude the possibility that BACH2 may also indirectly affect IL-2 expression. However, the ChIP data and the human IL-2 proximal promoter driven luciferase assay suggest BACH2 regulates IL-2 directly at the proximal promoter.
During primary stimulation, naive UCB CD4 þ T cells have reproducibly exhibited both reduced Th1-associated cytokine, specifically IFN-g and TNF-a, 43, 44 as well as significant changes in the composition of the transcription factors NFAT1, AP1 and BACH2. 3 Therefore, UCB CD4 þ T cell has the unique response for the co-stimulation of normal IL-2 expression coupled with rapid proliferation, which could have significant physiological and clinical ramifications in the allogeneic setting. This may alter the developmental fate of UCB donor CD4 þ T cells responding to recipient antigen presenting cells. The unique transcription factor regulation of Th1 cytokines in UCB graft CD4 þ T cells would expectedly impact both the cytokine and cellular cascade necessary to amplify UCB donor T-cell alloreactivity to recipient antigens in vivo.
2, 45 The immunologically competent UCB CD4 þ T cells in a graft, although capable of recognizing noninherited antigens, do not elicit normal Th1 cytokine levels directing the expansion and differentiation of these alloreactive T cells. Although further studies of UCB CD4 þ T-cell development in vivo in the context of infusion into HLA-disparate UCB allogeneic stem cell transplantation are warranted, these analyses of BACH2 transcription factor regulation of IL-2 in UCB graft CD4 þ T cells provide a new understanding of mechanisms promoting a unique response to CD3/CD28 engagement. These analyses may guide future studies to delineate cellular and molecular mechanisms contributing to UCB allogeneic immune tolerance. ) were transiently transfected with pGL3Basic, pGL3hIL-2lucifierase, pTK-renilla, and either control siRNA or Broadcomplex-Tramtrack-Bric-a-Brac and Cap'n'collar homology 1 bZip transcription factor 2 (BACH2) siRNA at a ratio of 2 mg:100 ng:2 mg, respectively, using the Amaxa Nucleofector system. Total and renilla luciferase were measured in cell lysates (20 ml). All experiments were performed in triplicate. Data is from three separate transfection experiments. Error bars represent the s.e.m. (P ¼ 0.05).
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